Innate Pharma
IPHA
Innate Pharma (IPHA) earnings history
Most recent quarter
- Fiscal period
- Q4 2025
- Period end
- Dec 31, 2025
- EPS actual
- −$0.35
- EPS estimate
- −$0.35
- EPS surprise
- +0.00%
- Revenue surprise
- +0.00%
- Revenue
- $5.7M
- Revenue estimate
- $5.7M
- Reported
- Mar 26, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q4 2025 | Mar 26, 2026 | −$0.35 | −$0.35 | +0.00% | $5.7M | SEC |
Quarterly revenue
Frequently asked questions
When did Innate Pharma (IPHA) last report earnings?
Innate Pharma last reported on Mar 26, 2026, covering fiscal Q4 2025.
Did IPHA beat earnings estimates?
Innate Pharma reported EPS of −$0.35 for Q4 2025, in line with the −$0.35 consensus estimate.
How much revenue did IPHA report last quarter?
Innate Pharma reported $5.7M in revenue for Q4 2025, against a consensus estimate of $5.7M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.